These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Immune reconstitution syndrome following initiation of antiretroviral therapy in a patient with HIV infection and multidrug-resistant tuberculosis. Swaminathan S; Padmapriyadarsini C; Narendran G; Thomas BE; Anand S; Rajyalakshmi A Indian J Chest Dis Allied Sci; 2005; 47(4):299-304. PubMed ID: 16255403 [TBL] [Abstract][Full Text] [Related]
45. The most restrictive alternative. O'Connell J Med Health R I; 1996 Jan; 79(1):35-6. PubMed ID: 8705889 [No Abstract] [Full Text] [Related]
46. Resectional surgery combined with chemotherapy remains the treatment of choice for multidrug-resistant tuberculosis. Shiraishi Y; Nakajima Y; Katsuragi N; Kurai M; Takahashi N J Thorac Cardiovasc Surg; 2004 Oct; 128(4):523-8. PubMed ID: 15457152 [TBL] [Abstract][Full Text] [Related]
48. Tuberculosis control goals unlikely to be met by 2005. Sharma DC Lancet; 2004 Apr; 363(9415):1122. PubMed ID: 15068013 [No Abstract] [Full Text] [Related]
49. [Treatment and outcomes of tuberculosis with multidrug resistance of MBT in children and adolescents]. Panova LV; Ovsiankina ES Probl Tuberk Bolezn Legk; 2007; (5):20-2. PubMed ID: 17600925 [TBL] [Abstract][Full Text] [Related]
50. Do we have evidence for policy changes in the treatment of children with latent tuberculosis infection? Lobato MN; Jereb JA; Castro KG Pediatrics; 2009 Mar; 123(3):902-3. PubMed ID: 19255018 [No Abstract] [Full Text] [Related]
52. [Efficacy of chemotherapy for tuberculosis in patients who isolate drug-resistant strains of M. tuberculosis with different genotypes]. Vasil'eva IA; Andreevskaia SN; Smirnova TG; Chernousova LI; Chukanov VI Probl Tuberk Bolezn Legk; 2004; (8):25-8. PubMed ID: 15478554 [TBL] [Abstract][Full Text] [Related]
53. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis]. Zierski M Tuberkuloza; 1966; 18(1-3):300-6. PubMed ID: 16296101 [No Abstract] [Full Text] [Related]
54. [50-year-old woman with pulmonary infiltrates]. Díaz M; Martín N; Fraile JM; Zamora FX Med Clin (Barc); 2009 Sep; 133(8):321; author reply 321-2. PubMed ID: 19493549 [No Abstract] [Full Text] [Related]
55. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK; Kim JH; Kang H; Cho JS; Smego RA Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [TBL] [Abstract][Full Text] [Related]
56. [Enhancing the efficiency of treatment in patients with multidrug resistant pulmonary tuberculosis by a combination of surgery and adequate chemotherapy]. Erimbetov KD Probl Tuberk Bolezn Legk; 2003; (4):39-41. PubMed ID: 12774419 [TBL] [Abstract][Full Text] [Related]
57. [A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar]. Ramarokoto H; Andrianasolo D; Rasolonavalona T; Ramaroson F; Razafitsiarovana I; Vincent V; Ratsimba L; Rasolofo Razanamparany V Arch Inst Pasteur Madagascar; 2003; 69(1-2):37-40. PubMed ID: 15678814 [TBL] [Abstract][Full Text] [Related]
58. NIAID describes research priorities for fighting drug-resistant tuberculosis. Home Healthc Nurse; 2008 Sep; 26(8):448-9. PubMed ID: 18787482 [No Abstract] [Full Text] [Related]
59. [Clinical aspects and therapy of tuberculosis of the lung]. Weinecke W Z Arztl Fortbild (Jena); 1986; 80(16):669-72. PubMed ID: 3538685 [No Abstract] [Full Text] [Related]